Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Microgenics Corporation — Predicate Candidate Screening
21 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
147 daysmedian FDA review time
241 days90th percentile
21clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K243498 | Alinity c Benzodiazepines Reagent Kit | Microgenics Corporation | 2024-12-11 | 29 | 0 |
| K240670 | DRI Ecstasy Plus Assay | Microgenics Corporation | 2024-10-30 | 233 | 0 |
| K231020 | Alinity c Tricyclic Antidepressants Reagent Kit | Microgenics Corporation | 2023-11-17 | 221 | 0 |
| K231007 | CEDIA Heroin Metabolite (6-AM) Assay | Microgenics Corporation | 2023-09-27 | 173 | 0 |
| K213875 | DRI TM Tricyclics Serum Tox Assay | Microgenics Corporation | 2022-12-21 | 373 | 0 |
| K211973 | DRI Cocaine Metabolite Assay | Microgenics Corporation | 2021-09-24 | 91 | 0 |
| K192943 | CEDIA Heroin Metabolite (6-AM) assay | Microgenics Corporation | 2019-12-16 | 59 | 0 |
| K190968 | CEDIA Benzodiazepine Assay | Microgenics Corporation | 2019-12-09 | 241 | 0 |
| DEN180030 | QMS Plazomicin Immunoassay | Microgenics Corporation | 2018-11-19 | 147 | 0 |
| K181499 | DRI Cocaine Metabolite Assay | Microgenics Corporation | 2018-07-06 | 29 | 0 |
| K173963 | DRI Benzodiazepine Assay | Microgenics Corporation | 2018-02-21 | 55 | 0 |
| K173195 | DRI Hydrocodone Assay | Microgenics Corporation | 2018-02-13 | 134 | 0 |
| K173183 | CEDIA Heroin Metabolite (6-AM) Assay | Microgenics Corporation | 2017-11-22 | 51 | 0 |
| K163101 | CEDIA Buprenorphine II Assay; CEDIA Buprenorphine II Calibra | Microgenics Corporation | 2017-04-06 | 150 | 0 |
| K150502 | DRI Hydrocodone Assay, DRI Hydrocodone Calibrators, DRI Hydr | Microgenics Corporation | 2015-10-09 | 225 | 0 |
| K123518 | ABBOTT CARBAMAZEPINE ASSAY | Microgenics Corporation | 2013-06-05 | 203 | 0 |
| K120936 | ABBOTT TDM MULTICONSTITUENT CALIBRATOR, THERMO SCIENTIFIC QM | Microgenics Corporation | 2012-12-13 | 260 | 0 |
| K122291 | THERMO SCIENTIFIC MAS OMNI-CARDIO | Microgenics Corporation | 2012-08-31 | 31 | 0 |
| K110738 | THERMO SCIENTIFIC MAS OMNI-CORE | Microgenics Corporation | 2011-11-03 | 231 | 0 |
| K103656 | THERMO SCIENTIFIC MAS R DOA TOTAL | Microgenics Corporation | 2011-03-24 | 99 | 0 |
| K092749 | MAS AND MINI-TROL PTH CONTROL | Microgenics Corporation | 2009-12-03 | 86 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda